P2Y12 adenosine receptor inhibitors preloading among patients with non-ST-elevation acute coronary syndromes; insights from a nationwide multicenter registry.

Ziad ArowHezzy ShmueliEdward Koifman Rami BarashiAbid AssaliLuham MahajnaKatia OrvinRoy BeigelYigal AbramowitzGal Tsaban

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)

Among patients with NSTEACS referred for an invasive strategy, the P2Y12-RI posttreatment strategy was associated with similar 30-day and 1-year MACE as the pretreatment strategy. These large-scale, multicenter, real-world data provide reassurance on the safety and efficacy of delaying P2Y12-IR until after coronary stratification to improve clinical decision-making.

Keyphrases

decision making
acute coronary syndrome
cross sectional
coronary artery disease
coronary artery
clinical trial
big data
antiplatelet therapy
machine learning
atrial fibrillation
binding protein
artificial intelligence
deep learning
data analysis
ejection fraction